Article Text

Download PDFPDF
Veterinary Medicines
Rory Cooney, Head of Biologicals, Veterinary Medicines Directorate, responds
  1. Rory Cooney, head of biologicals
  1. VMD, Woodham Lane, New Haw, Addlestone, Surrey KT15 3LS
  1. email: r.cooney{at}vmd.gov.uk

Statistics from Altmetric.com

Before a veterinary medicinal product (VMP) (including a vaccine) can be placed on the UK market, a large package of quality, safety and efficacy data undergoes a rigorous independent scientific assessment.

Vaccines must be shown to be safe to use. Where necessary, specific warnings are added to the product literature which, when followed, will minimise the risk of any known potential adverse reactions.

A rigorous assessment of user safety is conducted for each product. In the case of live zoonotic bacterial vaccines, the human pathogenicity of the vaccine strain in the …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.